NCT03846804View on ClinicalTrials.gov

Next-Generation Sequencing for Pathogen Detection and Quantification in Children With Musculoskeletal Infections

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

June 2, 2022

Study Completion Date

June 2, 2022

Conditions
Musculoskeletal InfectionAcute Hematogenous OsteomyelitisSeptic ArthritisOsteomyelitisPyomyositis
Interventions
DIAGNOSTIC_TEST

Karius Test

Next-generation sequencing of blood and synovial fluid samples for pathogen identification in children with musculoskeletal infections

Trial Locations (1)

46202

Riley Hospital for Children, Indianapolis

All Listed Sponsors
collaborator

Karius, Inc.

INDUSTRY

lead

Indiana University

OTHER

NCT03846804 - Next-Generation Sequencing for Pathogen Detection and Quantification in Children With Musculoskeletal Infections | Biotech Hunter | Biotech Hunter